A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT04008797 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Neoplasms
Neoplasms
Carcinoma, Hepatocellular
Liver Neoplasms
Colorectal Neoplasms

Interventions

DRUG: E7386
DRUG: Lenvatinib
DRUG: Doxorubicin
DRUG: Paclitaxel

Sponsor

Eisai Inc.